drugset / Trial / NCT06833203

Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome

NCT06833203

Completed 60 enrolled Cairo University
RandomizedParallel-groupDouble-blindPrevention

Summary

This study aims to evaluate the additive effect of Amantadine to Pregabaline in the development of post-thoracotomy pain syndrome.

Timeline

Start
2023-12-01
Primary completion
2025-05-01
Completion
2025-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amantadine Unknown 100 mg
Comparator Pregabalin Small molecule 75 mg

Indications

No indication recorded.